Voltar à classificação

Walgreens Boots Alliance, Inc. (WBA)

NEGATIVE

Fundamental

~0

Preço

$-

Capitalização de Mercado

-

Parte 1 · Quanto vale a empresa

Visão Geral

Sem descrição disponível.

No editorial profile for this company yet

Direct competitors

Who this company fights with for the same customers

No editorial profile for this company yet

No competitor list for this company yet.

Dados financeiros limitados disponíveis (0% das métricas). As pontuações podem não refletir com precisão os fundamentos desta empresa.

Balanço & Liquidez

Receita

-

Resultado Líquido

-

Fluxo de Caixa Livre

-

Capital Próprio Total

-

Passivo Total

-

Rácio de Liquidez

0.68

Cobertura de Juros

-

Dívida/EBITDA

-

Resultados Por Ação

Receita & Resultado Líquido

Fluxo de Caixa Livre

Decomposição dos Resultados

Demonstração histórica

Margens ao longo do tempo

A dívida ao longo do tempo

Quanto pesa a dívida

Grelha do crescimento

Crescimento — Receitas

Métricas de Avaliação

Rácio P/E

-

ROE

-72.7%

Rácio P/B

-

P/FCF

-

Margem Bruta

-

ROIC

-

Radar de Rentabilidade

Value Creation (Economic Moat)

ROIC

-

WACC

8.0%

ROIC − WACC

-

Critérios de Análise Fundamental

Aprovado (0)

Reprovado (0)

Indisponível (1)

  • Error fetching data

Piotroski F-Score

-/9

Preocupações financeiras graves

Qualidade dos Resultados

-

Baixa qualidade: investigar a contabilidade

Diluição de Ações

-

A recomprar ações. Favorável ao acionista

Governação

Parte 2 · O preço e o momento de entrar

Esta parte não serve para saber se a empresa vale: serve para escolher quando comprá-la, depois que os fundamentos te convenceram. Dentro: análise técnica, potencial, quedas históricas, exposição gama.

Latest News

Recent headlines for WBA, sourced from Markets Gazette.

  • 6/9/2026NEUTRAL
    Boots Owner in Talks on Possible $10 Billion Sale, FT Says

    Walgreens Boots Alliance, the parent company of the UK health and beauty retailer Boots, is reportedly in discussions for a potential sale valued at approximately $10 billion. The Financial Times reports that potential suitors include the Weston family and Australian pharmacy group Sigma Healthcare Ltd. This news indicates a significant strategic move by WBA, potentially reshaping its portfolio. Investors will monitor the progress of these talks, as a sale could unlock value or signal a divestment of a key, albeit underperforming, asset.

  • 4/2/2026POSITIVE
    Walgreens’ Private Equity Owner Plans to Double Pharmacy Chain’s Profits

    The private equity owner of Walgreens has outlined ambitious plans to double the pharmacy chain's profitability within the coming years, following a substantial $10 billion acquisition. This strategic initiative, revealed by sources close to the deal, signals a strong conviction in Walgreens' turnaround potential. Investors will be closely watching the execution of these plans, which are expected to focus on operational efficiencies and market expansion. The news suggests a potential upside for the company's valuation, pending successful implementation of the private equity firm's growth strategy.

  • 2/23/2026NEGATIVE
    Walgreens widens job cuts amid store closures

    Walgreens Boots Alliance is escalating its restructuring efforts, announcing a new wave of job cuts and significant store closures. This action is part of a broader trend of distress within the U.S. retail pharmacy sector, highlighted by similar moves from competitors like CVS, which has laid off workers to focus on online delivery, and the bankruptcy of Rite Aid. Walgreens' strategy aims to cut costs and streamline its physical footprint to navigate a rapidly changing market and intense competitive pressure. Investors are closely watching to see if these drastic measures will be enough to reverse the negative trend and set the company back on a path to sustainable growth, amidst a landscape also marked by store closures from giants like Amazon.

via Markets Gazette